Skip to main contentSkip to navigation
Sirius Investors
Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

IONS
NASDAQHealthcare

Revenue Analysis - IONS

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

IONS Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Commercial Member

0.0% of total revenue

$107.8M

Royalty

0.0% of total revenue

$58.3M

Product

0.0% of total revenue

$43.0M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Collaborative Agreement Revenue
Commercial
Commercial Member
Other Commercial
Product
Product Sales, Net
Research and Development Revenue
Royalty
SPINRAZA Royalties
TEGSEDI and WAYLIVRA
3/31/2026$0$0$107.8M$0$43.0M$0$0$58.3M$0$0
12/31/2025$0$0$217.5M$0$64.3M$0$0$75.7M$0$0
9/30/2025$0$0$115.6M$0$31.8M$0$0$75.7M$0$0
6/30/2025$0$0$102.8M$0$19.3M$0$0$70.0M$0$0
3/31/2025$45.0M$76.2M$0$5.7M$0$6.3M$55.4M$64.2M$48.0M$5.7M
12/31/2024$146.2M$145.3M$0$32.1M$17.1M$0$200.8M$0$102.1M$0

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
Commercial Member-50.4%
Product-33.1%
Royalty-23.0%

Earnings Reports

Want to see how IONS's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports